Table 3

Subgroup analysis of deployment and military retention rates for the medical and procedural treatment strategies

All
(n=365)
Deployed
(n=147)
Non-deployed
(n=218)
Retained
(n=248)
Discharged
(n=117)
Medical therapies for AF
No medical therapy55 (15%)23 (16%)32 (15%)39 (16%)16 (14%)
Rate medical therapy146 (40%)60 (41%)86 (39%)95 (38%)51 (44%)
Rhythm medical therapy164 (45%)64 (44%)100 (46%)114 (46%)50 (43%)
Rates of PVI for AF
No PVI211 (58%)81 (55%)130 (60%)136 (55%)75 (64%)
PVI154 (42%)66 (45%)88 (40%)112 (45%)42 (36%)
History of anticoagulation management for AF
No anticoagulation194 (53%)75 (51%)119 (55%)125 (50%)69 (59%)
Warfarin119 (33%)58 (39%)61 (28%)89 (36%)30 (26%)
Direct oral anticoagulant52 (14%)14 (10%)38 (17%)34 (14%)18 (15%)
  • Values are number, (%).

  • AF, atrial fibrillation; PVI, pulmonary vein isolation.